Company / Current Liabilities per Share
Beam Therapeutics Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.95
FY2025
5-year range
$0.95 / $3.14
FY2021-FY2025
Trend
-56.2%
vs FY2024
Sector context
#117 of 210
Health Care
What the data says
At $0.95, Beam Therapeutics Inc.'s current liabilities per share ranks #94 of 210 in the Health Care sector. Current Liabilities per Share has declined for 3 consecutive years, from $3.14 in FY2022 to $0.95 in FY2025.
Based on SEC 10-K filings.
0.95 in FY2025 with a 5-year CAGR of -41.6%.
Improved from $2.52 to $0.95 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -32.8%
- 5-Year CAGR
- -41.6%
- 10-Year CAGR
- -
Sector benchmark
#94 of 210 in Health CareTop 44% of 210This company $0.95 Sector average $23.79
▼
-96.0% below sector average
Key checks
Key Insights
- Beam Therapeutics Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 56.2% year-over-year.
- Ranks #117 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.95 | -56.2% |
| FY2024 | $2.18 | -13.6% |
| FY2023 | $2.52 | -19.7% |
| FY2022 | $3.14 | +0.5% |
| FY2021 | $3.12 | -77.7% |
| FY2020 | $13.97 | +210.6% |
| FY2019 | $4.50 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026